NCT06345209 - Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels | Biotech Hunter

Enrollment

236

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Coronary Artery Disease

Interventions

DEVICE

Sirolimus-coated Coronary Balloon Dilatation Catheter

During PCI, percutaneous transluminal coronary angioplasty is performed on the target lesion using the Sirolimus-coated Coronary Balloon Dilatation Catheter in the test group, subsequently completing the remaining procedure

DEVICE

Drug-coated Coronary Balloon Dilatation Catheter

During PCI, percutaneous transluminal coronary angioplasty is performed on the target lesion using the Drug-coated Coronary Balloon Dilatation Catheter in the test group, subsequently completing the remaining procedure

All Listed Sponsors

collaborator

Chinese Academy of Medical Sciences, Fuwai Hospital

OTHER

lead

BrosMed Medical Co., Ltd

INDUSTRY